✦ LIBER ✦

Evaluation of radiation therapy factors in prophylactic central nervous system irradiation for childhood leukemia: A report from the Children's Cancer Study Group

✍ Scribed by Giulio J. D'angio; Philip Littman; Mark Nesbit; Harland Sather; Robert Hittle; Jorge Ortega; Milton Donaldson; Denman Hammond

Publisher: Elsevier Science
Year: 1981
Tongue: English
Weight: 1013 KB
Volume: 7
Category: Article
ISSN: 0360-3016
DOI: 10.1016/0360-3016(81)90155-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Radiation therapy (RT) factors in prophy

Radiation therapy (RT) factors in prophylactic central nervous system (CNS) irradiation for childhood leukemia : A report from Children's Study Group (CCSG)

✍ P. Littman; G.J. D'Angio; M. Nesbit; H. Sather; J. Ortega; M. Donaldson; D. Hamm 📂 Article 📅 1979 🏛 Elsevier Science 🌐 English ⚖ 73 KB

The increasing incidence of central nerv

The increasing incidence of central nervous system leukemia in children. (Children's cancer study group a)

✍ Audrey E. Evans; Ethel S. Gilbert; Richard Zandstra 📂 Article 📅 1970 🏛 John Wiley and Sons 🌐 English ⚖ 514 KB

Prognostic factors and therapy in acute

Prognostic factors and therapy in acute lymphoblastic leukemia of childhood: CCG-141: A report from childrens cancer study group

✍ Denis R. Miller; Sandford Leikin; Vincent Albo; Harland Sather; Myron Karon; Den 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 811 KB

Phase 2 study of temozolomide in childre

Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors : A report from the Children's Oncology Group

✍ H. Stacy Nicholson; Cynthia S. Kretschmar; Mark Krailo; Mark Bernstein; Richard 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB 👁 1 views

## Abstract ## BACKGROUND. Effective chemotherapy is lacking for most types of central nervous system (CNS) tumors in children. Temozolomide, an agent with activity against adult brain tumors, was investigated in children and adolescents with recurrent CNS tumors. ## METHODS. Temozolomide was ad

Evaluation of cyclocytidine in reinducti

Evaluation of cyclocytidine in reinduction and maintenance therapy of children with acute nonlymphocytic leukemia previously treated with cytosine arabinoside: A report from children's cancer study group

✍ Movassaghi, Nasser ;Higgins, Gussie ;Pyesmany, Allan ;Baehner, Robert ;Chard, Ro 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 438 KB

A study of children in relapse with acute nonlymphocytic leukemia (ANLL) previously maintained in remission with combination chemotherapy including cytosine arabinoside (Ara-C) was undertaken by Children's Cancer Study Group (CCSG) to assess the efficacy of cyclocytidine (Cyclo-C), a depot Ara-C, co

Granulocyte-macrophage colony-stimulatin

Granulocyte-macrophage colony-stimulating factor in association with high-dose chemotherapy (VETOPEC) for childhood solid tumors: A report from the Australia and New Zealand Children's Cancer Study Group

✍ McCowage, Geoffrey B.; White, Les; Carpenter, Paul; Lockwood, Lianne; Toogood, I 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 3 views

## Purpose: Combination chemotherapy with vincristine, etoposide, and high-dose, escalating cyclophosphamide (vetopec) is an effective regimen in pediatric patients with high-risk solid tumors. the toxicity of the regimen is predominantly haematologic. this study addressed the role of recombinant h